Treco Douglas A
SEC insider (Form 3/4/5 filer). CIK 0001688192. Director at CRISPR Therapeutics AG (CRSP) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in BOSTON, MA.
Companies Treco Douglas A has filed insider reports for
- CRISPR Therapeutics AG (CRSP): Director
- Inozyme Pharma, Inc. (INZY): Director, Officer, CEO
Treco Douglas A
CIK: 0001688192
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 5, 2026CRSP
CRISPR Therapeutics AG
AwardDirectStock Option (Right to Buy)
13K shares- - Aug 6, 2025CRSP
CRISPR Therapeutics AG
PurchaseDirect20K shares at avg. $57.03$1.1M - Jul 1, 2025INZY
Inozyme Pharma, Inc.
DispositionDirectRestricted Stock Units
150K shares- - Jul 1, 2025INZY
Inozyme Pharma, Inc.
Tender OfferDirect43.9K shares at avg. $4.00$175K - Jul 1, 2025INZY
Inozyme Pharma, Inc.
DispositionDirectStock Option (Right to Buy)
87K shares- - Jul 1, 2025INZY
Inozyme Pharma, Inc.
DispositionDirectStock Option (Right to Buy)
400K shares- - Jun 25, 2025INZY
Inozyme Pharma, Inc.
AwardDirect2.8K shares at avg. $0.74$2K - Jun 5, 2025CRSP
CRISPR Therapeutics AG
AwardDirectStock Option (Right to Buy)
13K shares- - Apr 2, 2025INZY
Inozyme Pharma, Inc.
SaleDirect8.8K shares at avg. $0.89$8K - Apr 1, 2025INZY
Inozyme Pharma, Inc.
ExerciseDirect25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  CRSP CRISPR Therapeutics AG | Award Stock Option (Right to Buy) | 13,000 | - | - | Direct |
| Aug 6, 2025 | CRSP CRISPR Therapeutics AG | Purchase | 20,000 | $57.03 | $1,140,600 | Direct |
| Jul 1, 2025 |  INZY Inozyme Pharma, Inc. | Disposition Restricted Stock Units | 150,000 | - | - | Direct |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | Tender Offer | 43,861 | $4.00 | $175,444 | Direct |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | Disposition Stock Option (Right to Buy) | 86,979 | - | - | Direct |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | Disposition Stock Option (Right to Buy) | 400,000 | - | - | Direct |
| Jun 25, 2025 | INZY Inozyme Pharma, Inc. | Award | 2,815 | $0.74 | $2,083 | Direct |
| Jun 5, 2025 | CRSP CRISPR Therapeutics AG | Award Stock Option (Right to Buy) | 13,000 | - | - | Direct |
| Apr 2, 2025 | INZY Inozyme Pharma, Inc. | Sale | 8,819 | $0.89 | $7,849 | Direct |
| Apr 1, 2025 | INZY Inozyme Pharma, Inc. | Exercise | 25,000 | - | - | Direct |
1-10 of 13 transactions